Suchergebnisse - "Nguyen, Bach"

PubPharm (4)

1

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD) : 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2018

von Molina, J. | Squires, K. | Sax, P. | +113

CommentIn: Lancet HIV. 2018 May;5(5):e200-e201. - PMID 29592841

2

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection : a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2017

von Cahn, P. | Kaplan, R. | Sax, P. | +122

CommentIn: Lancet HIV. 2017 Nov;4(11):e476-e477. - PMID 28918878

3

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1 : a substudy of the NEAT001/ANRS143 randomised trial

enthalten in: The lancet. HIV | 2015

von Bernardino, J. | Mocroft, A. | Mallon, P. | +115

CommentIn: Lancet HIV. 2015 Nov;2(11):e452-3. - PMID 26520920

4

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION) : a non-randomised, open-label trial

enthalten in: The lancet. HIV | 2015

von Rockstroh, J. | Nelson, M. | Katlama, C. | +16

ErratumIn: Lancet HIV. 2015 Aug;2(8):e316

1
[1]